Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP812576.RAR1HZuFvTrM5iAonhAqTQQ4hMZcfcRCzCwI49CAru7Sw130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812576.RAR1HZuFvTrM5iAonhAqTQQ4hMZcfcRCzCwI49CAru7Sw130_provenance.
• assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP248607.RAWauZnGVXJcv791BW6a9GLFWd5pTZRAlKGV0X5JDMgZA130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248607.RAWauZnGVXJcv791BW6a9GLFWd5pTZRAlKGV0X5JDMgZA130_provenance.
• NP395021.RAZIkTsOZqkv8BNurna5RxXByiZZs5p5fe98kwQxue1kY130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395021.RAZIkTsOZqkv8BNurna5RxXByiZZs5p5fe98kwQxue1kY130_provenance.
• NP395238.RAYPrjkA6OB_aB9rL3LIzQvLNJnMWwVcDiS8qOEd81yLk130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395238.RAYPrjkA6OB_aB9rL3LIzQvLNJnMWwVcDiS8qOEd81yLk130_provenance.
• NP248513.RAu7px8YPtIwkRiY0-ABMgW33RutD7J8Gph50kLCuVBGw130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248513.RAu7px8YPtIwkRiY0-ABMgW33RutD7J8Gph50kLCuVBGw130_provenance.
• NP407527.RAZc-Rv8myEUGADiveBuP10rR1kLydvHV_Nw_n3oEDOrM130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407527.RAZc-Rv8myEUGADiveBuP10rR1kLydvHV_Nw_n3oEDOrM130_provenance.
• NP407528.RAmLecAhxHg5E4W7DWXj6Rihw2ky338S6ivLe5Puk7_MI130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407528.RAmLecAhxHg5E4W7DWXj6Rihw2ky338S6ivLe5Puk7_MI130_provenance.
• NP407532.RAoImdm-lUIC3Afdd0mwjwqe8rvYusY-xwDmWml1hkcf4130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407532.RAoImdm-lUIC3Afdd0mwjwqe8rvYusY-xwDmWml1hkcf4130_provenance.
• NP395323.RAGVygdEmb6mLpZyFes12AdPgyYEFF32xP2IbNTbjan08130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395323.RAGVygdEmb6mLpZyFes12AdPgyYEFF32xP2IbNTbjan08130_provenance.
• NP407534.RAGmorX6PUABR5JAiYNhkcF2B7fdkonaxQVAPCwVFo6vM130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407534.RAGmorX6PUABR5JAiYNhkcF2B7fdkonaxQVAPCwVFo6vM130_provenance.
• NP407529.RA6epgSxKzgROMWaeRjMaJhXLvEqymmxshiEjHWIu1Srk130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407529.RA6epgSxKzgROMWaeRjMaJhXLvEqymmxshiEjHWIu1Srk130_provenance.
• NP407531.RA5REdlPiN06Wdlzou2zwghYOCBiCDnc57QnknvZ6Q9v4130_assertion description "[The FAS antigen (CD95/APO-1) is suggested to be a tumor suppressor gene since mice and patients with congenital FAS mutations are prone to B cell lymphomas and somatic FAS mutations are described in hematological and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407531.RA5REdlPiN06Wdlzou2zwghYOCBiCDnc57QnknvZ6Q9v4130_provenance.